Infectious Disease Alert
RSSArticles
-
Infectious Disease Alert Updates
Wee Bacterium Parasitizes Other Oral Bacteria; How Safe Is Your Honey?; Benefits of TB Screening Confirmed
-
Can the Human Papillomavirus Vaccine Cure Cervical Dysplasia?
In this randomized, controlled trial, the HPV 16/18 vaccine did not hasten resolution of existing oncogenic HPV infections nor prevent persistent HPV 16/18 associated infection and cervical dysplasia recurrence after loop electrosurgical excisional procedure treatment.
-
VRE and MRSA: Should We Stop Routine Contact Precautions?
The value of routine contact precautions for VRE and MRSA is strongly challenged.
-
Empirical Antifungals in the ICU — Probably Not Helpful
Two hundred sixty non-neutropenic ICU patients with clinical evidence of sepsis receiving broad-spectrum antibiotics and known to be colonized by Candida species were randomized to micafungin for 14 days vs. placebo. Empirical micafungin therapy did not increase invasive fungal infection-free survival at 28 days.
-
Cranberry Capsules Are Not Effective in Preventing Bacteriuria with Pyuria in Elderly Women in Nursing Homes
A randomized, double-blind, placebo-controlled trial found that giving cranberry capsules to elderly women residing in nursing homes did not result in any significant benefits, including no reduction in symptomatic urinary tract infections.
-
Subacute Sclerosing Panencephalitis
Subacute sclerosing panencephalitis is a lethal complication of measles that is not as rare as previously believed.
-
CDC Recommends Simpler HPV Vaccine Series for Young Adolescents
The CDC has changed its recommendation for the human papillomavirus vaccine administration from a routine three-dose series to a two-dose series for 9- to 14-year-old children.
-
Infectious Disease Alert Updates
Staphylococcus aureus Bacteremia Increased in Families; Atypical Mycobacterial Infection in Cardiac Surgery Patients
-
FDA Is Approving New Antibiotics — But Is the Result Just Higher Prices for More of the Same?
Eight new antibiotics received FDA approval from 2010-2015.
-
Warning: Reactivation of Hepatitis B Virus Coinfection During Treatment of Chronic Hepatitis C Virus Infection
Prior to initiation of hepatitis C virus treatment with direct-acting antivirals, patients should be screened for hepatitis B virus coinfection. Those who are hepatitis B virus-infected should receive ongoing monitoring for flares and reactivation of hepatitis B.